Getting off methadone can feel daunting. Many people start methadone to escape another opioid, then find themselves dependent on methadone instead. The withdrawal is real, it comes on slowly, more intensely, and it tends to last longer than withdrawal from most other opioids. That long, drawn-out course is what makes quitting methadone so hard. If you or someone you love is trying to stop, this guide is for you. Understanding what happens in your body is the first step toward a clear decision. You are not alone, and the path forward is more defined than it may feel right now.
What Is Methadone?
Methadone is a long-acting, synthetic opioid. Medical providers prescribe it for two main reasons: to treat opioid dependency and to manage severe, long-term pain. In dependency care, it is given as Medication-Assisted Treatment (MAT) through licensed opioid treatment programs (OTPs). At first, most people take it daily on-site; take-home doses are earned as they stabilize. Methadone eases cravings and can prevent an overdose. Even so, it still creates its own dependency, which is why many people later look for a way off it.
QUICK FACTS: METHADONE
- Drug Type
- Long-acting synthetic opioid; also used in Medication-Assisted Treatment (MAT)
- Withdrawal Onset
- 24-36 hours after last dose (delayed by methadone’s long half-life)
- Withdrawal Peak
- Days 5-7 after last dose
- Withdrawal Duration
- Acute phase about 10-14 days for most; up to 2-3 weeks after high doses or long-term use. PAWS: weeks to months.
Why Does Methadone Withdrawal Happen?
Withdrawal happens when someone who became dependent on methadone cuts back or stops taking it. When you take methadone regularly, it binds to mu-opioid receptors across your central nervous system (CNS). Over time, your body adapts. It multiplies its opioid receptors and produces fewer of its own natural pain-relieving chemicals, called endorphins. Your body comes to rely on methadone just to function normally.
When methadone is removed, your body is left out of balance. The overpopulated opioid receptors still expect the drug, but your suppressed endorphin production cannot keep up. The result is the physical and mental distress known as methadone withdrawal.
Methadone behaves differently from short-acting opioids. It has a long half-life, meaning the drug leaves your body slowly. On average, that half-life is about 24 hours, but it ranges widely, from roughly 8 to 59 hours from one person to the next. Because the drug clears so slowly, withdrawal starts late and drags on. Your liver breaks methadone down using enzymes that vary a lot between people, so two patients on the same dose can have very different experiences.
How hard your withdrawal becomes depends on several factors. These include how long you used methadone, the dose you maintained, and your liver function. Your metabolic rate also matters, since it affects how quickly your body clears the drug. Higher doses, longer use, and a slower metabolic rate all tend to make withdrawal longer and more intense.
Methadone Withdrawal Symptoms
Early Symptoms
- Anxiety and restlessness
- Sweating and chills
- Runny nose and watery eyes
- Yawning
- Muscle and joint aches
- Dilated pupils
- Trouble sleeping
- Goosebumps
- Early opioid cravings
Symptoms Peak
- Severe muscle, bone, and joint pain
- Heavy sweating and chills
- Nausea, vomiting, and diarrhea; significant dehydration risk
- Stomach cramps
- Elevated blood pressure and rapid heart rate
- Fever
- Restless legs and severe insomnia
- Intense anxiety and panic
- Depression and low mood
- Overwhelming opioid cravings; highest relapse-risk window
Acute Symptoms Subsiding
- Gradual drop in nausea and stomach issues
- Easing muscle and joint pain
- Heart rate and blood pressure returning to normal
- Lingering but lessening insomnia
- Ongoing low mood and anxiety
- Fatigue and low energy
- Continued opioid cravings
Post-Acute Withdrawal Syndrome (PAWS)
- Persistent anxiety and panic episodes
- Depression and inability to experience joy
- Mood swings and emotional ups and downs
- Poor focus and memory
- Insomnia lasting months
- Low energy and fatigue
- On-and-off opioid cravings; a major relapse trigger
PAWS is a group of mainly psychological symptoms that linger after the acute phase ends. For methadone, PAWS often sets in around 3 to 6 weeks after acute withdrawal and can last for months or even years. It persists because your body’s natural pain-relief system has not yet rebalanced. Your CNS keeps signaling distress long after the drug is gone. Methadone’s slow clearance is part of why this whole process, including PAWS, takes so long.
Methadone Withdrawal Timeline
Early withdrawal begins. Onset is delayed by methadone’s long half-life. Flu-like symptoms appear: runny nose, watery eyes, yawning, sweating, and muscle aches. Anxiety, restlessness, and cravings emerge.
Symptoms reach their worst, usually around days 5 to 7. Nausea, vomiting, and diarrhea dominate and raise the risk of dehydration. Muscle and bone pain, severe insomnia, restless legs, and heavy sweating peak. Anxiety, depression, and cravings are strongest. This is the highest-risk window for relapse.
Acute physical symptoms start to ease. Sleep problems, low mood, and cravings often persist.
People on high doses or long-term methadone may still feel physical symptoms during this stretch.
A drawn-out post-acute phase follows. Mainly psychological symptoms remain: anxiety, depression, inability to experience joy, mood swings, insomnia, and episodic cravings. These cravings can drive relapse.
Common Approaches to Quitting Methadone
All of the traditional ways to quit methadone focus on detox and symptom relief. None of them fix the underlying problem that drives withdrawal. Each one handles the experience differently; none resolve the disruption in your body’s chemistry behind it.
Cold Turkey
Cold turkey means stopping methadone abruptly, with no taper and no medication. People choose it for its accessibility; it requires no clinic enrollment, prescriptions, or waiting.
This method does not fix the underlying disruption of the endorphin-opioid receptor system. With methadone, cold turkey produces an especially long and punishing withdrawal, because the drug clears so slowly. Heavy vomiting and diarrhea can cause dangerous dehydration. Relapse risk is highest during the peak phase, around days 5 to 7. Relapse after any time off is especially dangerous because your tolerance has dropped, which sharply raises the risk of overdose and death.
Supervised Tapering
A supervised methadone taper is a slow, medically guided reduction of your dose over time. Your OTP lowers the dose in small steps so your body can adjust. In theory, this eases the severity of peak withdrawal compared with stopping suddenly.
This method does not fix the underlying disruption of the endorphin-opioid receptor system. Relapse after a taper is very common, and lasting success is hard to hold. Even a careful taper leaves your opioid receptors overpopulated and your endorphin production suppressed. Methadone’s long half-life means each dose drop can still bring drawn-out discomfort. Cravings and PAWS continue.
Switching to Another MAT Opioid
Some people transition from methadone to another MAT opioid, such as buprenorphine or Suboxone. There are several switching options. This is sometimes used to lower cardiac risk, since methadone can prolong the QT interval, a heart-rhythm change tied to higher doses.
This approach does not fix the underlying disruption of the endorphin-opioid receptor system. While a MAT opioid keeps activating your opioid receptors, your body cannot wither those overpopulated receptors or restore its natural endorphin production. The switch also has to be timed carefully. Buprenorphine can push methadone off the receptor and trigger sudden, severe withdrawal, called precipitated withdrawal. To avoid it, medical providers usually lower the methadone dose first, often to about 30 to 40 mg per day. They then wait for early withdrawal to appear before starting buprenorphine. Even when the switch goes smoothly, you remain dependent on an opioid, and you must find a way to quit the new MAT opioid too.
Medical Detox / Inpatient Rehab
Inpatient detox offers 24/7 medically supervised withdrawal management: monitoring of vital signs, fluids for dehydration, and comfort medicine. Counseling and behavioral therapy usually follow.
This approach does not fix the underlying disruption of the endorphin-opioid receptor system. It can help manage the acute phase but leaves the root cause in place. Because methadone withdrawal is so protracted, symptoms often outlast a standard inpatient stay. PAWS continues after discharge, and relapse risk lasts for months to years.
Why Traditional Approaches Don't Lead to Lasting Results
None of these approaches produce lasting results. To see why, look at what they have in common, not just how they differ.
Passive Restoration
Cold turkey, supervised tapering, and inpatient detox all lean on the same basic mechanism: time. The idea is simple; remove the drug and wait for your body to restore its own endorphin-opioid receptor balance. But during that wait, your opioid receptors stay overpopulated, your endorphin production stays suppressed, and your body keeps signaling a deficit. The result is PAWS, cravings, and biological pressure to relapse for months, sometimes years, after the last dose. With methadone, that waiting period is even longer compared to some other opioids, because the drug clears so slowly.
Substitution
Switching to another MAT opioid frames dependency transfer as treatment. One opioid replaces another. Your body cannot restore its natural endorphin production while a MAT opioid keeps activating your opioid receptors. People who move between MAT opioids often go years without reaching full opioid independence. Anyone who then tries to stop the new opioid can face withdrawal just as strong as, or stronger than, methadone.
How ANR Treats Methadone Dependency at the Source
ANR (Accelerated Neuro-Regulation) is the only treatment that directly targets the endorphin-opioid receptor disruption that drives methadone dependency. Developed by Dr. Andre Waismann, Founder of ANR Clinic, ANR Treatment does not manage symptoms or swap one opioid for another. Instead, it restores the endorphin-opioid receptor system to its pre-dependency state. ANR has safely treated more than 25,000 patients worldwide. 9 out of 10 patients remain opioid-free long-term. No traditional approach can match that outcome.
25,000+
Patients treated globally
9 out of 10
Patients remain opioid-free long-term
ANR follows a structured four-stage framework. Preparation: Treatment begins right away, before hospitalization. Each patient receives an individualized pre-admission clinical evaluation based on their dependency profile, medical history, drug use, and any other conditions. Regulation: The hospital stay lasts about 36 hours, with 4 to 6 hours under sedation for the procedure itself. During this phase, withdrawal is induced while the patient is asleep, so the patient does not experience its symptoms. Opioid receptor modulation takes place during this phase, restoring the endorphin-opioid receptor balance that existed before the dependency developed. Stabilization: Patients are seen for 3 days of post-discharge in-person follow-ups. Any temporary discomfort during this period is like bouncing back from surgery; discomfort is healing, not illness. Optimization: Over 6 to 12 months, the system is optimized for lasting receptor health. This includes nutrition, physical activity, mental engagement, and daily naltrexone as prescribed. Naltrexone is a non-opioid that blocks opioid receptors, creates no dependency, and helps protect against relapse.
STAGE 1
Preparation
STAGE 2
Regulation
STAGE 3
Stabilization
STAGE 4
Optimization
Here is where ANR Treatment stands apart. Every traditional approach (cold turkey, tapering, switching opioids, inpatient detox) discharges patients into weeks or months of PAWS. Anxiety, depression, inability to experience joy, insomnia, and cravings continue after treatment ends, creating a long window of relapse risk. That window is even longer with methadone because of its slow clearance. ANR resolves PAWS during hospitalization and the stabilization period. By the time an ANR patient completes stabilization, the endorphin-opioid receptor system has been restored to balance. The biological driver of PAWS has been addressed; it is not left to fade on its own over months. This is one of ANR’s most meaningful advantages.
Frequently Asked Questions About Quitting Methadone
How long does methadone withdrawal last?
Acute methadone withdrawal usually begins 24 to 36 hours after your last dose. It peaks around days 5 to 7 and eases for most people within 10 to 14 days. After high doses or long-term use, physical symptoms can run up to 3 weeks. PAWS, which mainly includes psychological symptoms, can last for months or even years after that.
Why is methadone withdrawal more drawn out than other opioids?
Methadone has a long half-life. On average, it is about 24 hours, and it can range from roughly 8 to 59 hours between people. The drug leaves your body slowly, which delays the start of withdrawal and stretches out its course. That is also why the first symptoms usually do not appear until about a day after your last dose, rather than within hours.
Is it safe to stop methadone cold turkey?
Stopping methadone suddenly, without medical support, produces the most severe and drawn-out withdrawal. Heavy vomiting and diarrhea can lead to dangerous dehydration. Relapse risk climbs, especially during the peak phase around days 5 to 7. Relapse after time off is especially risky, because your tolerance has dropped; that sharply raises the risk of overdose and death. Medical supervision during methadone cessation is strongly recommended.
Can I switch from methadone to Suboxone to get off?
Yes, this is done in clinical care, but the timing matters. Buprenorphine, the active ingredient in Suboxone, can displace methadone at the receptor and trigger sudden, severe precipitated withdrawal. To avoid it, doctors usually lower your methadone dose first, often to about 30 to 40 mg per day. They then wait for early withdrawal signs before starting buprenorphine. Switching can also lower cardiac risk, since methadone can prolong the QT interval at higher doses. Even so, you stay dependent on an opioid, and you will also have to find a way to quit buprenorphine later on.
What is the cost of ANR Treatment for methadone dependency?
The full cost of ANR Treatment is $21,500. This is an elective medical procedure and is not covered by insurance; however, financing options are available. The price is one-time and includes preparation, hospitalization, the procedure, and follow-up care. To learn more, visit anrclinic.com/financing. For people who have cycled through opioid addiction treatment programs and other treatments for years, ANR offers a different path: a single, definitive step designed to end opioid dependency at its biological root. Contact ANR Clinic for a free consultation to discuss your situation.
Related Articles
Sources / References
- Medications for Opioid Use Disorder — Treatment Improvement Protocol (TIP) 63, Chapter 3B: Methadone. SAMHSA / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK574918/
- Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence — Drug interactions involving methadone and buprenorphine (QT prolongation). World Health Organization / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK143177/
- Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. World Health Organization / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK310652/
- Opioid Withdrawal. StatPearls [Internet]. National Library of Medicine / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK526012/
- Opiate and Opioid Withdrawal. MedlinePlus Medical Encyclopedia. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/000949.htm
- Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients: A Critical Review. Frontiers in Pharmacology (2021). https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.718811/full
- Waismann, A., Kabemba, A., Medowska, O., Salzman, R., Philpott, C., & Patel, M.M. (2023). Hemodynamic and Pulmonary Safety Profile of the Accelerated Neuroregulation Procedure. NeuroRegulation, 10(4), 253-259. https://doi.org/10.15540/nr.10.4.253